CSPC Pharmaceutical Group Limited
(Incorporated in Hong Kong with limited liability)

Announcements & Notices       

2015-December-31	TERMS OF REFERENCE OF THE AUDIT COMMITTEE (in PDF)
2015-December-9	POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 9 DECEMBER 2015 (in PDF)
2015-November-30	UNAUDITED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2015 (in PDF)
2015-November-19	NOTICE OF EXTRAORDINARY GENERAL MEETING (in PDF)
2015-November-18	DATE OF BOARD MEETING (in PDF)
2015-November-16	FURTHER DELAY IN DESPATCH OF CIRCULAR (in PDF)
2015-November-12	DELAY IN DESPATCH OF CIRCULAR (in PDF)
2015-November-2	FORMATION OF INDEPENDENT BOARD COMMITTEE AND APPOINTMENT OF INDEPENDENT FINANCIAL ADVISER (in PDF)
2015-November-1	CONTINUING CONNECTED TRANSACTION-MASTER SALES AGREEMENT (in PDF)
2015-October-26	(1) APPLICATION FOR WHITEWASH WAIVER;(2) PROPOSED ADOPTION OF THE NEW SHARE OPTION SCHEME;AND(3) RE-ELECTION OF RETIRING DIRECTOR (in PDF)
2015-September-7	LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION (in PDF)
2015-September-7	CHANGES OF EXECUTIVE DIRECTOR (in PDF)
2015-August-25	CHANGE OF COMPANY WEBSITE (in PDF)
2015-August-25	2015 INTERIM RESULTS ANNOUNCEMENT (in PDF)
2015-August-13	Date of Board Meeting (in PDF)
2015-August-5	VOLUNTARY ANNOUNCEMENT - THE GROUP'S COUGH SUPPRESSANT PRODUCT "BENZONATATE SOFT CAPSULE" WAS GRANTED DRUG REGISTRATION APPROVAL BY THE U.S. FDA (in PDF)
2015-May-26	List of Directors and their Role and Function (in PDF)
2015-May-26	RETIREMENT OF EXECUTIVE DIRECTOR AND COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES (in PDF)
2015-May-26	POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 26 MAY 2015 (in PDF)
2015-May-26	UNAUDITED RESULTS FOR THE THREE MONTHS ENDED 31 MARCH 2015 (in PDF)
2015-May-13	DATE OF BOARD MEETING (in PDF)
2015-April-17	NOTICE OF ANNUAL GENERAL MEETING (in PDF)
2015-April-17	SALE OF EXISTING SHARES BY A SUBSTANTIAL SHAREHOLDER (in PDF)
2015-April-13	PROPOSED ADOPTION OF NEW ARTICLES OF ASSOCIATION (in PDF)
2015-March-24	ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014 (in PDF)
2015-March-12	Date of Board Meeting (in PDF)
2015-February-27	NON-COMPLIANCE WITH RULE 3.10A OF THE LISTING RULES (in PDF)
2015-January-19	VOLUNTARY ANNOUNCEMENT - THE GROUP'S ONCOLOGY DRUG WAS GRANTED PHASE II/III CLINICAL TRIAL APPROVAL (in PDF)
2024	2024 Announcements & Notices
2023	2023 Announcements & Notices
2022	2022 Announcements & Notices
2021	2021 Announcements & Notices
2020	2020 Announcements & Notices
2019	2019 Announcements & Notices
2018	2018 Announcements & Notices
2017	2017 Announcements & Notices
2016	2016 Announcements & Notices
2014	2014 Announcements & Notices
2013	2013 Announcements & Notices
2012	2012 Announcements & Notices
2011	2011 Announcements & Notices
2010	2010 Announcements & Notices
2009	2009 Announcements & Notices
2008	2008 Announcements & Notices
2007	2007 Announcements & Notices
2006	2006 Announcements & Notices